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The mammalian gastrointestinal (GI) microbiota is highly adapted to thrive in the GI environment and per-
forms key functions related to host nutrition, physiology, development, immunity, and behavior. Successful
host-bacterial associations require chemical signaling and optimal nutrient utilization and exchange. Howev-
er, this important balance can be severely disrupted by environmental stimuli, with one of the most common
insults upon the microbiota being infectious diseases. Although the microbiota acts as a barrier toward
enteric pathogens, many enteric pathogens exploit signals and nutrients derived from both the microbiota
and host to regulate their virulence programs. Here we review several signaling and nutrient recognition sys-
tems employed by GI pathogens to regulate growth and virulence. We discuss how shifts in the microbiota
composition change host susceptibility to infection and how dietary changes or manipulation of the micro-
biota could potentially prevent and/or ameliorate GI infections.Introduction
The mammalian GI tract is a complex environment where bacte-
rial-host associations are paramount. The gut is populated by a
dense and diverse microbiota that is intrinsically connected
to host health and disease states. It is now appreciated that in
addition to providing nutrients and vitamins, the microbiota im-
pacts the host’s metabolism, immune and digestive systems,
behavior, and neurological diseases (Ferreyra et al., 2014a;
Hooper et al., 2002; Sampson and Mazmanian, 2015; Sharon
et al., 2014; Sommer and Ba¨ckhed, 2013). Moreover, the micro-
biota has been historically regarded as a barrier to enteric
pathogens, commonly referred to as colonization resistance
(Bohnhoff et al., 1954; Mushin and Dubos, 1965). These diverse
roles of the gut microbiota have to be coordinated among the
hundreds of different bacterial species and the host itself. This
coordination is achieved through an array of chemicals that
range from signaling molecules to metabolites and several that
moonlight in both roles. The chemistry within the intestine is
diverse but still poorly understood (Marcobal et al., 2013).
Many enteric pathogens exploit this intestinal chemistry to
recognize the environment and gauge host physiology. These
pathogens are crafty in recognizing different microbiota, as
well as host-derived signals and nutrients to coordinate expres-
sion of their virulence traits, and adjust their metabolism to
ensure successful competition for nutrients and a colonization
niche (Hughes and Sperandio, 2008; Pifer and Sperandio, 2014).
Bacterial pathogens sense these chemicals through diverse
receptors that generally are themselves transcription factors,
or relay this information to transcription factors. Many of these
signals and/or nutrients are sensed by membrane-bound histi-
dine sensor kinases (HKs) that increase their phosphorylation
in response to these signals and initiate an intracellular signaling
cascade within the bacterial cell, where the kinase transfers
the phosphate to a response regulator (RR) that is activated
upon phosphorylation. The vast majority of the RRs are tran-
scription factors that regulate expression of different sets of
genes, coordinating the response of the bacterial cell to certainCenvironmental cues. Together, the HK and the RR comprise a
two-component signaling (TCS) system. In addition to TCSs,
bacterial cells also recognize signals/nutrients through intracel-
lular receptors that are themselves transcription factors. Upon
binding their specific chemical ligands, these intracellular recep-
tors change their conformation, either increasing or decreasing
their affinity to DNA to modify gene expression (Sperandio and
Freitag, 2012).
These signaling systems often regulate a vast array of viru-
lence factors that determine the success of an infection. Enteric
pathogens have different adhesins to promote adherence to
epithelial cells, specialized secretion systems such as the sy-
ringe-like type three secretion systems (T3SSs) to translocate
bacterial effectors to host cells to highjack their function, as
well as toxins that can either change signal transduction or kill
eukaryotic cells among many other virulence genes. The genes
encoding these virulence factors have usually been horizontally
acquired through transposition, conjugation, or phage transduc-
tion and are spatially clustered in pathogenicity islands (PAI)
(Kaper and Hacker, 1999). Virulence genes are generally em-
ployed as competition tools by enteric pathogens to gain access
to unique niches inaccessible to the microbiota (Kamada et al.,
2012), such as the interface with the intestinal epithelium, and
to invade and survive within epithelial cells and macrophages.
However, expression of this virulence repertoire can be energet-
ically expensive, and dysregulated expression is onerous to the
pathogen. To ensure the correct timing and niche for expression
of these traits, pathogens survey the chemistry landscape within
the gut.
In this review we examine how several enteric pathogens
actually thrive with the ‘‘naive’’ aid of certain members of the mi-
crobiota. They interpret signal and nutritional cues from both the
microbiota and the host to assess competition for nutrients and
colonization sites, coordinating virulence and metabolism to
ensure optimal colonization of the host. We discuss the various
signaling systems employed by these pathogens to recognize
these cues and entertain how differences in microbiotaell Host & Microbe 18, September 9, 2015 ª2015 Elsevier Inc. 275
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biotic treatment may impact the course of enteric infections.
The Microbiota and Nutrient Utilization in the Gut
The GI tract contains a wide variety of nutrients from several
different sources, both endogenous and exogenous (Koropatkin
et al., 2012; Sonnenburg et al., 2005). The host produces a
mucosal layer to protect the epithelia, consisting of heavily gly-
cosylated mucin proteins. Mucosal glycans contain multiple
different sugar residues (Larsson et al., 2009) that are important
nutrient sources for the microbiota as well as intestinal patho-
gens. Carbohydrates, amino acids, and other nutrients
consumed in the host diet feed luminal bacterial populations
and are constantly changing based on host diet. Finally, different
members of the microbiota produce a variety of metabolic by-
products that can be utilized by other species or influence their
physiology. The nutrients present in the gut have profound ef-
fects on the composition of the bacterial community but also
act as signals to influence the physiology of both commensal
and invading pathogenic microbes.
Microbiota Generation of Nutrients
The GI tract is home to hundreds of bacterial species, all surviv-
ing on a finite number of resources. This gives rise to an incred-
ibly complex food web where competition, cooperation, and
synergism all occur. In order to expand in this saturated environ-
ment, incoming pathogens must exploit portions of this nutri-
tional web to proliferate and successfully deploy their virulence
regime.
Certain members of the microbiota, most notably members of
the phylum Bacteroidetes, have a greatly expanded ability to
degrade complex carbohydrates (El Kaoutari et al., 2013). Other
species that lack the requisite enzymes to degrade these large
glycan structures can take advantage of sugars released during
this breakdown process as a nutrient source. Several recent
studies have demonstrated that microbiota-liberated sugars
are important nutrients for enteric pathogens when establishing
an infection. The ability to catabolize sialic acid, a sugar found
in the mucus layer, increases colonization levels of both
Clostridium difficile and Salmonella typhimurium in an antibi-
otic-treated mouse model, despite both of these organisms
lacking a sialidase enzyme to liberate this sugar. Instead, these
two pathogens depend on the sialidase activity of the micro-
biota, and an abundant commensal species, Bacteroides
thetaiotaomicron (B. theta), can restore the advantage of sialic
acid catabolism in germ-free mice (Ng et al., 2013). Interestingly,
B. theta does not have a catabolic pathway for sialic acid (Xu
et al., 2003) and presumably encodes this enzymatic activity
solely to access the underlying sugars inmucosal glycans, which
are a significant nutrient source for this organism (Martens et al.,
2008). Similarly, vancomycin-resistant Enterococcus, which
cannot grow on purified mucin, can grow on mucin pre-digested
with extracts from human stools, suggesting that it can take
advantage of microbiota-liberated mucosal sugars in the gut
(Pultz et al., 2006). These data demonstrate how diverse patho-
gens with different lifestyles have evolved a common strategy
for co-opting the glycosidic abilities of commensal microbes to
expand in the gut.
In addition to affecting the availability of sugars through
enzymatic activity, the microbiota can also directly influence276 Cell Host & Microbe 18, September 9, 2015 ª2015 Elsevier Inc.the production of mucosal glycans by the host. Probiotic
Lactobacillus species can increase expression of mucins by in-
testinal epithelial cells (Mack et al., 1999), altering the carbohy-
drate landscape of the mucosal layer. The microbiota is also
required for fucosylation of mucosal glycans, as fucose residues
are not found in the mucus layer of germ-free mice. Colonization
with B. theta can rescue this phenotype but is dependent on
B. theta’s ability to catabolize fucose (Bry et al., 1996; Hooper
et al., 1999).
In addition to affecting the availability of sugars, the micro-
biota produces a wide variety of metabolic by-products such
as gases, short-chain fatty acids, and organic acids that can
be utilized by enteric pathogens as nutrients. C. difficile relies
on succinate, an organic acid made by many members of the
gut microbiota as a by-product of anaerobic fermentation
(Reichardt et al., 2014), as an electron sink, converting it to buty-
rate to regenerate NAD+ (Ferreyra et al., 2014b). This allows
fermentation of dietary sugars like sorbitol, a sugar alcohol
whose levels increase following antibiotic treatment (a major
risk factor for C. difficile infection) (Theriot et al., 2014). The suc-
cinate to butyrate pathway confers a growth advantage to
C. difficile in vivo (Ferreyra et al., 2014b), suggesting that
C. difficile has evolved to take advantage of the nutrients in
the post-antibiotic gut. Molecular hydrogen is another abundant
by-product of anaerobic fermentation by the microbiota. The
hyb hydrogenase allows S. Typhimurium to utilize microbiota-
produced hydrogen as an energy source and enhances its
growth during the initial invasion stage of infection. This is
dependent on the microbiota as there is no advantage associ-
ated with hyb in germ-free mice (Maier et al., 2013). For patho-
gens entering the densely populated gut, co-opting molecules
produced by resident microbes is an important strategy for initial
expansion (Table 1).
Pathogens Create a Distinct Nutrient Niche
Although the gut environment contains a wide variety of
nutrients, the immense number of microbes creates intense
competition for resources. One mechanism to compete with
the microbiota is for pathogens to evolve a distinct metabolic
repertoire. In a streptomycin-treated mouse model, Enterohe-
morrhagic E. coli (EHEC) EDL933 and commensal E. coli strains
MG1655, Nissle 1917, and HS differ in which sugars they use to
establish and maintain colonization. Mutants defective in cata-
bolic pathways for each of the 12 sugars found in the mucus
layer revealed that each E. coli strain required a unique set of
sugars for full colonization (Fabich et al., 2008; Maltby et al.,
2013). Although EDL933 could colonize the intestines of mice
that were pre-colonizedwith any of the commensal strains alone,
pre-colonization with a combination of the three strains pre-
vented EDL933 colonization (Leatham et al., 2009). However,
the sugar utilization profile of E. coli Nissle 1917 and HS together
covers all of the sugars important for MG1655 colonization, and
accordingly, these two strains protect equally well as the three-
strain cocktail against EDL933 colonization (Maltby et al., 2013).
This provides evidence for a nutrient competition mechanism of
colonization resistance against pathogenic E. coli by closely
related strains. Notably, catabolic pathways for two substrates,
hexuronates (glucuronate and galacturonate) and sucrose, are
important for EDL933 colonization but are either not present or
not required for colonization by E. coli MG1655, Nissle 1917,
Table 1. Metabolites that Contribute to Pathogenesis
Metabolites Enhance Pathogen Expansion
Metabolite Source Pathogen References
Sialic acid Released from mucosa by microbiota S. Typhimurium, C. difficile Ng et al., 2013
Succinate By-product of microbiota fermentation C. difficile Ferreyra et al., 2014a, 2014b
Hydrogen By-product of microbiota fermentation S. Typhimurium Maier et al., 2013
Ethanolamine Mammalian and bacterial membranes EHEC, S. Typhimurium,
L. monocytogenes
Kendall et al., 2012; Bertin et al., 2011;
Thiennimitr et al., 2011; Joseph et al., 2006
Sorbitol Host diet C. difficile Theriot et al., 2014
Metabolites Influence Virulence Gene Expression
Metabolite Virulence Factor Controlled Regulator(s) Involved References
Ethanolamine Enhances LEE expression (EHEC) EutR Kendall et al., 2012
Succinate Enhances LEE expression (EHEC) Cra Curtis et al., 2014a, 2014b
Fucose Inhibits LEE expression (EHEC) FusKR two-component system Pacheco et al., 2012
Butyrate Inhibits SPI-1 expression
(S. Typhimurium)
unknown Lawhon et al., 2002; Gantois et al., 2006;
Hung et al., 2013
Enhances LEE expression (EHEC) Lrp/ PchA/ LeuO/ Ler Nakanishi et al., 2009; Takao et al., 2014;
Tobe et al., 2011
Enhances flagella expression (EHEC) Lrp and unknown
Lrp-independent pathway
Tobe et al., 2011
Propionate Inhibits SPI-1 expression
(S. Typhimurium)
HilD/ HilA Lawhon et al., 2002; Gantois et al., 2006;
Hung et al., 2013
Acetate Enhances SPI-1 expression
(S. Typhimurium)
BarA/SirA two-component
system/ HilA
Lawhon et al., 2002
Taurocholate Enhances C. difficile germination Theriot et al., 2014
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pathogenic E. coli has evolved partially distinct nutrient require-
ments from its commensal relatives.
Interestingly, the colonization defects observed for patho-
genic EDL933 upon loss of multiple catabolic pathways are
additive, suggesting this strain metabolizes multiple sugars
simultaneously. This phenomenon was not observed for
commensal MG1655, suggesting it utilizes available sugars in
a stepwise hierarchy (Fabich et al., 2008). This supports the
idea that not only has pathogenic E. coli evolved to utilize distinct
nutrients from commensal strains, but it also employs a different
metabolic strategy. This hypothesis is further supported by the
fact that EDL933 switches from using glycolytic to gluconeo-
genic substrates in a mouse gut pre-colonized with either
MG1655 or Nissle 1917, and an EDL933 mutant unable to utilize
gluconeogenic substrates cannot expand to or sustain wild-type
colonization levels under these conditions (Miranda et al., 2004;
Schinner et al., 2015). This demonstrates that in order to
compete with closely related commensal species that are highly
adapted for the gut, enteric pathogens have evolved unique
metabolic profiles and strategies.
Competition for nutrients occurs between more distantly
related species as well. Citrobacter rodentium, a mouse path-
ogen used as a model for EHEC disease, downregulates its
virulence genes by 21 days post-infection and is then outcom-
peted by the microbiota and cleared from the mouse gut. How-
ever, this phenomenon was shown to be dependent on nutrient
availability in a B. theta colonized gnotobiotic mouse model.
When mice are fed a diet containing both monosaccharides,
which can be utilized by Enterobacteriacae like C. rodentium,Cand polysaccharides, which can be utilized by Bacteroides
species, C. rodentium is able to colonize and cause disease.
However, when the mice are switched to a diet containing only
monosaccharides and the two species are forced to compete
for sugars, B. theta out-competes C. rodentium and the path-
ogen is cleared (Kamada et al., 2012). Establishing a unique
metabolic niche is crucial for invading pathogens to be able to
compete with commensal species and expand (Figure 2).
Usage of ethanolamine also allows pathogens a nutrient
source distinct from competing commensals. Ethanolamine is
a component of an abundant phospholipid in mammalian and
bacterial membranes and is found in the intestinal tract due to
epithelial cell turnover (Bertin et al., 2011). Ethanolamine can
be used as a carbon and/or nitrogen source by several intestinal
pathogens (Garsin, 2010), and in fact ethanolamine utilization
[eut] genes are preferentially found in the genomes of bacteria
that cause food-borne illness (Korbel et al., 2005). In the intestine
this metabolite can serve as a selective nutrient source for path-
ogens, as the majority of commensal species do not encode eut
genes. Ethanolamine utilization by S. Typhimurium and EHEC
provides a competitive growth advantage in the intestinal
tract (Bertin et al., 2011; Thiennimitr et al., 2011), and in Listeria
monocytogenes it enhances intracellular replication (Joseph
et al., 2006). Expression of the eut operon is modulated by global
regulators of virulence in S. Typhimurium, Enterococcus faecalis,
and L. monocytogenes, suggesting that ethanolamine utilization
is tied to virulence (Bourgogne et al., 2006; Kelly et al., 2004;
Lawhon et al., 2003; Toledo-Arana et al., 2009). Indeed, ethanol-
amine activates virulence gene expression in EHEC by binding to
the EutR transcription factor, demonstrating that it can be both aell Host & Microbe 18, September 9, 2015 ª2015 Elsevier Inc. 277
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Figure 1. Microbiota-Derived Nutrients
Feed Pathogenic Bacteria
Black arrows indicate production of a particular
nutrient; blue arrows indicate consumption of the
indicated nutrient. Members of the intestinal mi-
crobiota stimulate (green arrow) mucosal sugar
production by the host as well as produce glyco-
sidic enzymes that liberate mucosal sugars
(galactose, fucose, sialic acid, etc.) from host
mucin glycoproteins. Liberated mucosal sugars
can directly feed invading pathogen populations.
Fermentation of dietary and host-derived sugars by
the microbiota leads to production of SCFA,
hydrogen, and organic acids like succinate, which
can also serve as nutrient sources for pathogens
during infection. Epithelial cell turnover releases
ethanolamine into the lumen of the gut, where it can
serve as a selective nutrient for pathogen prolifer-
ation during inflammation.
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2014; Kendall et al., 2012; Luzader et al., 2013).
This scavenging of nutrients is critical for establishing coloni-
zation in the gut and requires the utilization of unique nutrient
sources in order to effectively compete with the hundreds of
commensal bacteria that occupy and proliferate within the GI
tract. Beyond providing these basic growth requirements, meta-
bolism and virulence are intimately intertwined and many patho-
gens have evolved to recognize metabolite cues as signals to
regulate virulence genes (Figure 1 and Table 1).
Microbiota-Derived Metabolites as Virulence Signals
Obtaining nutrients and proliferating is the first crucial step for
pathogens to establish a productive infection. However, after
proliferating to sufficient levels, pathogens must precisely
regulate when and where they will deploy their virulence pro-
gram. Microbiota-generated metabolites can act as signals
that regulate the production of virulence factors and ultimately
affect the progression of disease (Figures 1 and 2).
The nutritional state of the gut (nutrient rich versus nutrient
poor), which is profoundly affected by the microbiota, can be a
signal for inducing or repressing virulence genes. EHEC prefer-
entially activates expression of its locus of enterocyte efface-
ment (LEE) PAI in gluconeogenic versus glycolytic conditions.A B C
EHEC 
C. rodentium
Bacteroides 
spp. succinate
v
EHEC 
C. rodentium
L-fucose
LEE
v
Bacteroides
LEE
increased disease
Bacteroi
C. rode
simple sugars (mono- and di-saccharides) are present, commensal Bacteroides
eventually leads to clearance of the pathogen. When both simple sugars and co
saccharides, and pathogenic Enterobacteriaceae are able to utilize simple sugar
278 Cell Host & Microbe 18, September 9, 2015 ª2015 Elsevier Inc.The LEE encodes for a T3SS, an adhesion, and effectors that
are essential for EHEC to form attaching and effacing (AE) lesions
on enterocytes (Kaper et al., 2004). In the presence of low
glucose levels or the gluconeogenic substrate succinate, LEE
transcription levels are higher than when glucose is abundant.
This regulation occurs through the concerted effort of two
transcriptional regulators Cra and KdpE (Njoroge et al., 2012).
Cra is an intracellular transcription factor, which is a master
regulator of carbon metabolism that represses transcription of
glycolytic enzymes and activates gluconeogenic enzymes (Saier
and Ramseier, 1996). Cra senses fluctuations in sugar concen-
trations to modulate its function (Ramseier et al., 1993). When
E. coli is growing in the presence of glycolytic substrates,
there is accumulation of fructose-1-phosphate (F1P) and fruc-
tose-1,6-bisphosphate (FBP), which bind to Cra, decreasing its
binding affinity to DNA, consequently decreasing its regulatory
function, including LEE transcription in EHEC (Njoroge et al.,
2012; Ramseier et al., 1995; Saier and Ramseier, 1996). KdpE
is the RR of the KdpDE two-component system that regulates
various genes in response to osmotic stress (Jung et al., 1997).
However, both of these regulators have been co-opted in path-
ogenic E. coli to regulate virulence. Under gluconeogenic condi-
tions, Cra and KdpE interact while binding to different regions ofdes spp.
ntium
Figure 2. Modulation of Virulence by
Commensal Bacteroides
Commensal Bacteroides affect virulence and pro-
gression of disease by AE pathogens in several
ways.
(A) Bacteroides produce a significant amount of
succinate as a by-product of carbohydrate
fermentation. Succinate is sensed by EHEC and
C. rodentium and upregulates expression of the
LEE PAI.
(B) L-fucose is liberated from host mucin glyco-
proteins by fucosidases expressed by members
of the microbiota such as Bacteroides thetaiotao-
micron. Free fucose is sensed by EHEC and re-
presses the LEE PAI to prevent early activation of
this virulence factor before reaching the epithelium.
(C) Nutrient competition between Bacteroides spp.
and pathogenic Enterobacteriaceae significantly
affects the progression of disease. When only
and pathogens are forced to compete for nutrients, which limits growth and
mplex carbohydrates are present, Bacteroides will preferentially utilize poly-
s to proliferate and persist in the intestine.
QseC QseEFusK
QseFQseBFusR
fucose
Epi, NE, 
AI-3
LEE
Ler
EHEC
KdpECra
Epi, NE
gluconeogenic
conditions
Figure 3. Adrenergic and Nutrient Signals
Intersect to Control Expression of the
EHEC LEE
Host hormones epinephrine (Epi) and norepineph-
rine (NE), whose intestinal availability is modulated
by the microbiota, are recognized by two sensor
histidine kinases, QseC and QseE. QseC also
recognizes the microbiota-derived quorum-
sensing molecule AI-3. QseC and QseE phos-
phorylate (dotted line) their cognate response
regulators (RR) QseB and QseE, respectively, and
QseC also phosphorylates RRs KdpE and QseF.
KdpE interacts with the master regulator of carbon
metabolism Cra to activate Ler, which Cra also
activates under gluconeogenic conditions (e.g.,
low glucose levels, high levels of succinate). The
mucosal sugar fucose, whose liberation is micro-
biota dependent, is recognized by another HK
FusK. FusR, the cognate RR of FusK, represses
activation of the LEE. Expression of FusKR is
repressed by the QseC/QseE signaling cascade.
Cell Host & Microbe
Reviewthe ler promoter (that encodes the Ler transcription factor that
activates expression of all of the LEE genes; Mellies et al.,
1999), causing increased expression of the LEE genes involved
in T3SS and increasing AE lesion formation (Njoroge et al.,
2012). Cra and KdpE also regulate several other non-LEE en-
coded virulence factors, either together or individually, in
response to low glucose conditions (Njoroge et al., 2013).
Shigella flexneri also regulates virulence genes in response to
nutrient conditions, where glycolysis is tied to virulence gene
expression. S. flexnerimutants inhibited for glycolysis at various
stages display decreased expression of the virF and virB viru-
lence regulators, causing a loss of invasion plasmid antigen
expression and decreased cellular attachment and invasion
(Gore and Payne, 2010) (Figures 2 and 3).
Microbiota-produced metabolites can also be specifically
sensed by pathogens as signals to induce or repress virulence
genes. In a C. rodentium infection model, antibiotic-treated
mice that are reconstituted with high levels of B. theta before be-
ing infected display more severe pathology and succumbed to
disease more quickly than mice that were left depleted of their
microbiota. Metabolomics revealed that succinate levels are
significantly higher in the B. theta reconstituted mice compared
to non-reconstituted mice (Curtis et al., 2014a). Additionally,
succinate stimulates EHEC production of the T3SS component
EspA in vitro. This succinate response is mediated through the
carbon metabolism master regulator Cra (Curtis et al., 2014a),
suggesting that EHEC and C. rodentium sense the metabolic
environment of the gut through microbiota-produced metabo-
lites and regulate their virulence genes accordingly.
Aside from being indicators of the energy state of a particular
environment, metabolites can also be used as cues to determine
precise location within the gut, which is a critical factor for deter-
mining whether to express virulence genes. EHEC encodes the
FusKR TCS that senses themucosal sugar fucose and represses
expression of the LEE PAI. The genes encoding fusKR have
recently been horizontally acquired and are within the PAI OI-
20 (Pacheco et al., 2012). The fusKR genes were acquired by
EPEC O55:H7 that gave rise to EHEC O157:H7 (Reid et al.,
2000; Wick et al., 2005). This TCS is also present inCC. rodentium, suggesting that it is exclusively found in AE GI
pathogens that colonize the colon. It is noteworthy that FusKR
is not present in other commensal or pathogenic E. coli strains,
or enteric bacteria at large, and homologs are only found in
Enterococcus fecaelis, suggesting that EPEC O55:H7 acquired
fusKR from E. fecaelis and later evolved into EHEC O157:H7.
OI-20 genes are upregulated when EHEC is grown in the pres-
ence of mucus (Bai et al., 2011) and during infection of the
colonicmucus-producing cell line HT29, suggesting that expres-
sion of this TCS in mucus facilitates EHEC adaptation to the
mammalian intestine (Pacheco et al., 2012). Thus, it is tempting
to speculate that acquisition of OI-20 enhances EHEC’s capa-
bility to successfully compete for a niche in the colon.
Generation of the fucose signal is dependent on the micro-
biota, as several members of the microbiota, but not EHEC,
have the enzymatic capacity to cleave the sugar residues
frommucin glycoproteins. It is hypothesized that LEE repression
by fucose is to prevent early expression of the energetically
expensive T3SS and allow expression only once the pathogen
has passed through the mucosal layer to the host epithelium
(Pacheco et al., 2012). FusR is a RR that represses expression
of the LEE genes by repressing transcription of ler. FusK, the
HK of this TCS, autophosphorylates in response to fucose,
thus revealing a signal transduction mechanism that senses
fucose to regulate expression of the LEE as well as EHEC
intestinal colonization in the infant rabbit model of infection. In
addition to LEE regulation, FusKR also indirectly represses
expression of the fuc genes involved in fucose utilization through
regulation of the Z0461 hexose-phosphate-major facilitator
superfamily (MFS) transporter, also encoded within the OI-20
(Pacheco et al., 2012). EHEC competes with commensal
E. coli, but not B. theta, for the same carbon sources (e.g.,
fucose) within the mammalian intestine (Autieri et al., 2007;
Chang et al., 2004; Fabich et al., 2008; Fox et al., 2009; Kamada
et al., 2012; Miranda et al., 2004). Commensal E. coli, however,
are not found in close contact with the epithelia, being in the
mucus layer, where it is counter-productive for EHEC to invest
resources to utilize fucose when EHEC can efficiently use other
carbon sources such as galactose, hexorunates, and mannose,ell Host & Microbe 18, September 9, 2015 ª2015 Elsevier Inc. 279
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bich et al., 2008). Additionally, in contrast to commensal E. coli,
EHEC is found closely associated with the intestinal epithelium
(Miranda et al., 2004). Therefore, EHEC can utilize nutrients
exclusively available at the surface of the epithelial cells. Conse-
quently, the decreased expression of the fuc operon through
fucose-sensing by FusKR may prevent EHEC from expending
energy in fucose utilization in themucus layer, where it competes
with commensal E. coli for this resource, and focus on utilizing
other carbon sources (e.g., galactose, whose utilization is not
affected by FusKR, not used by this competitor). Thus, the colo-
nization defect of DfusK of the mammalian GI tract results from
its inability to correctly time virulence and metabolic gene
expression (Pacheco et al., 2012) (Figures 2 and 3).
Short-chain fatty acids (SCFA) are some of the most abundant
fermentation by-products produced by the microbiota in the in-
testinal tract. The most abundant three are acetate, propionate,
and butyrate, but the concentrations and proportions of these
molecules differ along the length and width of the gut. Therefore,
some enteric pathogens have evolved to sense SCFAs as bio-
markers of their location in the gut. Mixtures of acetate, propio-
nate, and butyrate in concentrations and proportions that mimic
the ileum enhance expression of the Salmonella pathogenicity
island 1 (SPI-1) by S. Typhimurium where colonic-like SCFA
mixtures suppress SPI-1 expression and inhibit cell invasion
(Lawhon et al., 2002). This reflects S. Typhimurium’s preference
for the ileum as the primary site for cell invasion (Carter and
Collins, 1974). More specifically, exposure to acetate alone en-
hances SPI-1 expression (Lawhon et al., 2002), while exposure
to butyrate and propionate decreases SPI-1 expression levels
(Gantois et al., 2006; Hung et al., 2013). The mechanism of
SPI-1 regulation by SCFA is not completely understood, but it
appears that the three SCFAs affect different parts of the SPI-1
regulatory cascade upstream of the HilA master regulator. Addi-
tionally, propionate and acetate must be internalized and con-
verted to propionyl-CoA and acetyl-CoA, respectively, to exert
their effects (Hung et al., 2013; Lawhon et al., 2002). In contrast
to Salmonella, EHEC deploys its virulence genes primarily in the
colon, and accordingly the effects of the different SCFAs on viru-
lence are reversed. In EHEC, exposure to butyrate increases
expression of the LEE PAI and enhances cell adherence, where
exposure to acetate and propionate had little to no effect on viru-
lence gene expression. This regulation is achieved through the
Lrp transcriptional regulator, which is post-transcriptionally acti-
vated in the presence of butyrate and initiates a regulatory
network involving several proteins that act cooperatively to
enhance and prolong LEE expression (Nakanishi et al., 2009;
Takao et al., 2014; Tobe et al., 2011). Exposure to SCFAs, espe-
cially butyrate, also increases expression of EHEC flagella
through the action of Lrp as well as a regulatory cascade inde-
pendent of that used to activate the LEE (Tobe et al., 2011)
(Figure 2).
Shifts in the Microbiota Affect Intestinal Pathogens
The microbiota is a dynamic community, and its composition is
influenced by several factors including diet, age, antibiotic use,
disease state, and others. These factors can influence not only
the membership and relative abundance of the species
composing the microbiota, but also their physiology, leading to280 Cell Host & Microbe 18, September 9, 2015 ª2015 Elsevier Inc.different metabolite profiles. These microbiota metabolite shifts
can have significant effects on host physiology as well as the
physiology of invading microbes, ultimately affecting disease
progression.
The composition of the microbiota is a central factor in deter-
mining susceptibility to enteric infection, and recent studies
have demonstrated that this community can be manipulated
to affect disease outcome. Distinct phylogenetic microbiota
compositions are observed between different strains of mice,
and correspondingly, different mouse strains naturally vary in
their susceptibly to enteric infection. While some of this can
be attributed to host genetics (Marquis and Gros, 2008), recent
studies demonstrate that differences in the microbiota
contribute significantly to the discrepancy between strains.
Transferring the microbiota of a susceptible mouse to a
resistant mouse, via antibiotic treatment and reconstitution,
increases pathogen loads and pathology associated with
C. rodentium infection. The reciprocal is also true where trans-
plantation of a resistant microbiota will confer some protection
to a genotypically susceptible mouse. Mice with a resistant
microbiota (naturally or via transplant) display higher levels of
pro-inflammatory cytokines, particularly IL-22, which aid in
clearance of C. rodentium and enhance survival (Ghosh et al.,
2011; Willing et al., 2011). Currently, a similar microbiota trans-
plantation technique is being used clinically to treat human
C. difficile infection (CDI). CDI is often preceded by antibiotic
use or another disturbance in the normal composition of the pa-
tient’s microbiota that decreases the diversity of the population
(Chang et al., 2008). Following transplantation from a healthy
donor, diversity of the community begins to rebound and the
community structure resembles that of the donor (Hamilton
et al., 2013; Song et al., 2013). This shift in microbiota compo-
sition corresponds with a successful recovery in CDI patients
receiving microbiota transplant (Khoruts et al., 2010), demon-
strating how the community can be manipulated to successfully
treat disease.
Antibiotic use has long been known to be a risk factor for infec-
tion by enteric pathogens (Pavia et al., 1990; Pe´pin et al., 2005).
Research over the past several years has revealed that one of the
mechanisms by which antibiotics decrease colonization resis-
tance by the microbiota is by shifting the metabolic environment
in a way that pathogens can exploit. Metabolomics revealed
numerous differences in the mouse intestine before and after
antibiotic treatment that correlated with susceptibility to
C. dificile infection. The metabolite landscape before antibiotic
treatment was more similar to mice allowed to recover from
treatment for 6 weeks (both resistant states) than tomice directly
following antibiotic treatment (susceptible state) (Theriot et al.,
2014). Following antibiotic treatment, there is an increase in
molecules that support C. difficile germination and growth. Me-
tabolites like sialic acid, sorbitol, and succinate that provide
C. difficile with a growth advantage in the gut all transiently in-
crease (Ferreyra et al., 2014b; Ng et al., 2013; Theriot et al.,
2014). Increased levels of taurocholate, a bile acid that enhances
C. difficile spore germination, are also observed after antibiotic
treatment (Theriot et al., 2014).
Metabolic shifts associated with changes in the microbiota
can also alter how the host is affected by certain virulence fac-
tors. Exposure to butyrate enhances host cell expression of
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cytotoxin common to EHEC and Shigella. When mice are fed a
high-fiber diet, the resulting increase in butyrate output by the
microbiota correlates with more severe pathology and faster
death during EHEC infection than that for mice on a low-fiber
diet that have lower intestinal butyrate levels (Zumbrun et al.,
2013). It is hypothesized that the shift in diet alters themicrobiota
such that more butyrate is being produced, which increases Gb3
expression on host cells and increases their susceptibility to
Shiga toxin. Conversely, a microbiota composition that pro-
duces increased acetate levels can protect against Shiga
toxin-mediated disease. In a lethal model of EHEC infection,
mice colonized with certain Bifidobacteria that lead to higher ac-
etate levels in the gut get less severe disease compared to mice
associated with Bifidobacteria strains that lead to lower acetate
levels. Microbiota-produced acetate increases barrier function
of the intestinal epithelium and prevents Shiga toxin from pass-
ing into the bloodstream (Fukuda et al., 2011). The composition
and metabolism of the microbiota is a critical factor in deter-
mining susceptibility to and progression of disease and repre-
sents an exciting new target for preventing and treating enteric
infection.
Integration of Nutritional and Adrenergic Signaling
in the Gut
The GI tract is highly innervated, and neurotransmitters are
prominent in the GI environment. These neurotransmitters have
important physiological functions in the gut where they modulate
intestinal smooth muscle contraction, submucosal blood flow,
and chloride and potassium secretion (Ho¨rger et al., 1998). There
is also an important relationship between neurotransmitters and
themicrobiota. Themicrobiota induces biosynthesis of serotonin
(Yano et al., 2015) and modulates the levels of the stress hor-
mones epinephrine and norepinephrine (NE) in the gut lumen
(Asano et al., 2012). Epinephrine and NE are at the core of stress
responses (Molina, 2006), and an important chemical exchange
within the gut involves these neurotransmitters. Both of them are
present in the gut, with NE being synthesized by the adrenergic
neuronswithin the enteric nervous system (ENS) (Furness, 2000).
Epinephrine is synthesized in the CNS and in the adrenal me-
dulla, but it can reach the gut through the bloodstream (Purves
et al., 2001). Stress has profound effects in GI function leading
to increased gastric acid production and intestinal motility and
has also been shown to alter the composition of the gut micro-
biota in animals subjected to premature separation from their
mothers (Grenham et al., 2011). Importantly, epinephrine and
NE can be detected in the lumen of the gut in their free active
form. The luminal levels of NE increase from the ileum to the co-
lon, with the higher concentrations being in the colon. Themicro-
biota plays a critical role in the availability of active NE in the
lumen. The host conjugates NE to glucuronic acid (glucuronide)
to inactivate it. The microbiota encodes glucuronidases that de-
conjugate glucuronic acid from NE, increasing the levels of free
biologically active NE in the lumen. In the lumen of germ-free
mice there is decreased free NE, with the majority of it being in
the glucuronide inactive form (Asano et al., 2012).
There is an extensive body of work showing that epinephrine
and NE increase virulence of several GI pathogens such as
EHEC, S. Typhimurium, and Vibrio parahaemolyticus (CurtisCand Sperandio, 2011; Moreira et al., 2010; Nakano et al., 2007;
Sperandio et al., 2003). The epinephrine/NE signaling cascade
has been elucidated in more detail in EHEC, where it increases
expression of the LEE, Shiga toxin, flagella, and motility (Hughes
et al., 2009; Sperandio et al., 2003). There are two bacterial
adrenergic receptors, QseC and QseE, which are HKs that in-
crease their autophosphorylation upon binding to epinephrine
or NE (Clarke et al., 2006; Reading et al., 2009). QseC phosphor-
ylates its cognate RRQseB, and the non-cognate RRs KdpE and
QseF, while QseE exclusively phosphorylates its cognate RR
QseF (Hughes et al., 2009; Reading et al., 2009; Yamamoto
et al., 2005). The concerted action of this signaling cascade in-
creases virulence gene expression in EHEC, but also leads to
profound metabolic changes that allow EHEC to successfully
colonize the colon (Curtis et al., 2014b; Hughes et al., 2009; Njor-
oge and Sperandio, 2012; Pacheco et al., 2012; Rasko et al.,
2008). Importantly, this bacterial adrenergic signaling cascade
intertwines with sensing and integrating signals and nutrient
cues provided by the gut microbiota. QseC, in addition to
sensing epinephrine and NE, also senses autoinducer 3 (AI-3),
which is a signal made by various members of the human micro-
biota, and is found in human stools (Sperandio et al., 2003;
Walters et al., 2006). Moreover, QseC phosphorylates KdpE
that interacts with Cra, which senses succinate produced by
B. theta, to activate LEE gene expression under gluconeogenic
conditions that mirror the environment at the interface with the
epithelium (Curtis et al., 2014a; Hughes et al., 2009; Njoroge
et al., 2012). The QseBC and QseEF TCSs also repress expres-
sion of the FusKR system that senses fucose released from the
mucus by B. theta to repress the LEE and adjust EHEC’s meta-
bolism when it is in the outer mucus layer environment (Pacheco
et al., 2012). This intricate relationship between adrenergic and
nutrient signaling equips EHEC with a fine-tuned signaling
cascade to sense the colonic environment of the host, in addition
to gaging whether it is in the lumen/outer mucus layer versus the
interface of the epithelium (Figure 3).
The survival of an organism lies within its intrinsic ability to
detect and efficiently respond to stress cues. Stress responses
play a key role in adaptation to environmental, psychosocial,
and physical insults. Hence, it comes as no surprise that stress
responses require synchronization and coordination of an organ-
ism’s resources to ensure that metabolic substrates are avail-
able to meet the increasing energy demands of an effective
stress response.
Trends for the Future
As we are at the brink of appreciating the complex relationship
between the host, gut microbiota, and enteric pathogens, we
are glancing at the exciting tip of an iceberg of knowledge. The
rapid development of new technologies in genomics, metage-
nomics, metabolomics, and transcriptomics are informing us
about differential microbiota compositions due to different diets,
host genetics, and physiology. It is also clear that this relation-
ship is a two-way street, with microbiota metabolites greatly
influencing host cell function. Moreover, the composition of the
microbiota seems to determine host susceptibility to enteric
pathogens. Some pathogens highjack microbiota and host-
derived signals and/or nutrients to promote disease and coordi-
nate the expression of their virulence repertoire. Conversely,ell Host & Microbe 18, September 9, 2015 ª2015 Elsevier Inc. 281
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infection. It is fascinating to ponder, for example, why during
an EHEC outbreak, in which the outbreak strain is the same,
there is a whole range of differential symptoms and disease
progression, with some having just watery diarrhea, others
developing hemolytic colitis, and a few progressing to hemolytic
uremic syndrome (HUS). There is also a distinct age susceptibil-
ity to HUS following an EHEC infection, with children generally
under 5 years of age being at higher risk (Kaper et al., 2004). It
is worthwhile considering that these differential disease progres-
sions may have an important microbiota composition compo-
nent to them. It has been well documented that one’s microbiota
establishes itself around the age of 5 (Rodrı´guez et al., 2015),
which coincides with the age range for enhanced susceptibility
to EHEC-induced HUS.
Different microbiota-derived metabolites have recently been
shown to be sensed by EHEC to promote or decrease its viru-
lence. Succinate, fucose, butyrate, and ethanolamine directly
influence EHEC’s gene expression toward enhancement of
virulence (Curtis et al., 2014a; Kendall et al., 2012; Nakanishi
et al., 2009; Pacheco et al., 2012). High-fiber diets increase the
concentration of butyrate upregulating expression of the Shiga
toxin receptor on host cells enhancing susceptibility to HUS
(Zumbrun et al., 2013). Meanwhile, acetate produced by
Bifidobacteria decreases translocation of Shiga toxin through
the intestine, protecting from HUS (Fukuda et al., 2011).
Themetabolite exchange among host, microbiota, and enteric
pathogens, combined with the intrinsic relationship with adren-
ergic signaling opens a whole array of possibilities on prevention
and/or amelioration/treatment of GI infections. It is tempting to
speculate that several drugs commonly used to interfere with
adrenergic signaling could be repurposed toward treatment of
enteric infections. One could also foresee changes in diet or
addition of supplements being explored as prebiotic therapy.
Finally, there is the consideration of directmanipulation of themi-
crobiota composition through pro-biotic approaches, or even
stool transplants that have been so successful in treating
C. difficile infections in humans.ACKNOWLEDGMENTS
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